Vanderbilt Institute of Chemical Biology
Cortez named interim chair in the Department of Biochemistry; York named Impossible Foods chief science officer
Dec. 8, 2020—David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods.
Aug. 19, 2020—A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely.
Jul. 27, 2020—The 16th annual Vanderbilt Institute of Chemical Biology Symposium is scheduled for Thursday, Aug. 6, from 8:30 a.m. to 5:15 p.m. CST. The event is sponsored by Ancora Innovation through Vanderbilt’s partnership with Deerfield Management and will be broadcast remotely.
Jan. 27, 2020—Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis.
May. 1, 2019—This year’s Vanderbilt Institute of Chemical Biology Annual Symposium will be held on Thursday, Aug. 8, in the Vanderbilt Student Life Center.
Dec. 19, 2018—The event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield.
Mar. 22, 2018—The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator.
Jan. 16, 2018—Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects.
Jul. 26, 2017—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56.
May. 18, 2017—Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development.
Nov. 3, 2016—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
Aug. 11, 2016—Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.